2005 Conference on Innovations and Challenges in Prostate Cancer Recommendations for Defining and Treating “High Risk” Disease
2005 Conference on Innovations and Challenges in Prostate Cancer
Recommendations for Defining and Treating High Risk Localized Prostate Cancer
Identifying Men Diagnosed With Clinically Localized Prostate Cancer Who are at High Risk for Death From Prostate Cancer
Defining High Risk Prostate Cancer With Risk Groups and Nomograms
Defining High Risk Prostate Cancer—Where do we Set the Bar? A Translational Science Approach to Risk Stratification
Identifying High Risk Patients
Initial Therapy With Radical Prostatectomy for High Risk Localized Prostate Cancer
The Case for Adjuvant Therapy for Prostate Cancer
Management of Locally Advanced Prostate Cancer
The Case for Systemic Therapy Alone for Prostate Cancer
The Case for Androgen Deprivation as Primary Therapy for Early Stage Disease
Bone Related Events in High Risk Prostate Cancer
Management of High Risk Localized Prostate Cancer
Management of High Risk Metastatic Prostate Cancer
High Risk Biochemical Relapse and the Timing of Androgen Deprivation Therapy
The Case for Secondary Hormonal Therapies in the Chemotherapy Age
The Case for Early Chemotherapy for the Treatment of Metastatic Disease
Management of High Risk Metastatic Prostate Cancer
Management of High Risk Metastatic Prostate Cancer